ArticleCureus2026
Extensive Axillary Nodal Metastasis Despite a Clinically Negative Axilla in Invasive Lobular Carcinoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive lobular carcinoma (ILC) is a distinct subtype of breast cancer characterized by an infiltrative growth pattern that frequently limits the accuracy of clinical examination and conventional imaging. Although most ILCs are hormone receptor-positive and are often associated with favorable prognostic expectations, accurate diagnosis and staging require careful integration of imaging findings, histopathologic assessment, and definitive surgical evaluation. We present the case of a 50-year-old premenopausal woman who presented with a progressively enlarging right breast mass of more than two months' duration. Clinical examination revealed a firm breast lesion with skin tethering and no palpable axillary lymphadenopathy. Imaging demonstrated an irregular non-mass lesion in the right breast, and biopsy confirmed ILC with strong estrogen and progesterone receptor positivity, HER2 negativity, low proliferative index, and loss of E-cadherin expression. Despite favorable tumor biology and a clinically negative axilla, intraoperative sentinel lymph node biopsy using dual tracer mapping with methylene blue dye and technetium-99m radiotracer identified metastatic involvement, prompting completion axillary lymph node dissection. Final pathology revealed eight positive lymph nodes with extranodal extension, corresponding to pT2 pN2a disease. The patient underwent right skin-sparing mastectomy with immediate reconstruction, followed by multidisciplinary planning for adjuvant systemic therapy, radiotherapy, and long-term endocrine therapy. This case highlights that hormone receptor-positive ILC may still harbor significant regional nodal disease, underscoring the importance of comprehensive staging and multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.